|
[1] TANAKA A,MA X,YOKOSUKA O,et al. Autoimmune liver diseases in the Asia-Pacific region:Proceedings of APASL symposium on AIH and PBC 2016[J]. Hepatol Int,2016,10(6):909-915.
|
|
[2] CHAZOUILLRES O. Overlap syndromes[J]. Dig Dis,2015,33(Suppl 2):181-187.
|
|
[3] JOSHITA S,UMEMURA T,TANAKA E,et al. Genetics and epigenetics in the pathogenesis of primary biliary cholangitis[J]. Clin J Gastroenterol,2018,11(1):11-18.
|
|
[4] LV T,LI M,ZENG N,et al. Systematic review and meta-analysis on the incidence and prevalence of autoimmune hepatitis in Asian,European,and American population[J]. J Gastroenterol Hepatol,2019,34(10):1676-1684.
|
|
[5] BOBERG KM,CHAPMAN RW,HIRSCHFIELD GM,et al. Overlap syndromes:The International Autoimmune Hepatitis Group(IAIHG)position statement on a controversial issue[J]. J Hepatol,2011,54(2):374-385.
|
|
[6] CZAJA AJ. Frequency and nature of the variant syndromes of autoimmune liver disease[J]. Hepatology,1998,28(2):360-365.
|
|
[7] CHAZOUILLRES O,WENDUM D,SERFATY L,et al. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome:Clinical features and response to therapy[J]. Hepatology,1998,28(2):296-301.
|
|
[8] European Association for the Study of the Liver. EASL Clinical Practice Guidelines:The diagnosis and management of patients with primary biliary cholangitis[J]. J Hepatol,2017,67(1):145-172.
|
|
[9] European Association for the Study of the Liver. EASL clinical practice guidelines:Autoimmune hepatitis[J]. J Hepatol,2015,63(4):971-1004.
|
|
[10] WANG TT,LU CL,FAN XL,et al. Clinical and pathological features of autoimmune hepatitis-primary biliary cholangitis overlap syndrome versus autoimmune hepatitis[J]. J Clin Hepatol,2017,33(11):2179-2185.(in Chinese)王婷婷，鲁昌立，凡小丽，等．自身免疫性肝炎-原发性胆汁性胆管炎重叠综合征的临床及病理学特征分析[J]．临床肝胆病杂志，2017,33(11):2179-2185.
|
|
[11] TAN XY,MIAO Q,CHEN XY. Clinicopathological analysis of anti-mitochondrial antibody negative primary biliary cholangitis-autoimmune hepatitis overlap syndrome[J]. Chin J Hepatol,2019,27(5):376-380.(in Chinese)谭晓燕，苗琪，陈晓宇．抗线粒体抗体阴性原发性胆汁性胆管炎-自身免疫性肝炎重叠综合征的临床病理分析[J]．中华肝脏病杂志，2019,27(5):376-380.
|
|
[12] LEE BT,WANG Y,YANG A,et al. IgG:IgM ratios of liver plasma cells reveal similar phenotypes of primary biliary cholangitis with and without features of autoimmune hepatitis[J]. Clin Gastroenterol Hepatol,2019.[Epub ahead of print]
|
|
[13] KUIPER EM,ZONDERVAN PE,van BUUREN HR. Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome[J]. Clin Gastroenterol Hepatol,2010,8(6):530-534.
|
|
[14] CZAJA AJ. Diagnosis and management of the overlap syndromes of autoimmune hepatitis[J]. Can J Gastroenterol,2013,27(7):417-423.
|
|
[15] ALVAREZ F,BERG PA,BIANCHI FB,et al. International Autoimmune Hepatitis Group Report:Review of criteria for diagnosis of autoimmune hepatitis[J]. J Hepatol,1999,31(5):929-938.
|
|
[16] MANNS MP,CZAJA AJ,GORHAM JD,et al. Diagnosis and management of autoimmune hepatitis[J]. Hepatology,2010,51(6):2193-2213.
|
|
[17] TALWALKAR JA,KEACH JC,ANGULO P,et al. Overlap of autoimmune hepatitis and primary biliary cirrhosis:An evaluation of a modified scoring system[J]. Am J Gastroenterol,2002,97(5):1191-1197.
|
|
[18] HENNES EM,ZENIYA M,CZAJA AJ,et al. Simplified criteria for the diagnosis of autoimmune hepatitis[J]. Hepatology,2008,48(1):169-176.
|
|
[19] WIEGARD C,SCHRAMM C,LOHSE AW. Scoring systems for the diagnosis of autoimmune hepatitis:Past,present,and future[J]. Semin Liver Dis,2009,29(3):254-261.
|
|
[20] MACK CL,ADAMS D,ASSIS DN,et al. Diagnosis and management of autoimmune hepatitis in adults and children:2019practice guidance and guidelines from the American Association for the study of liver diseases[J]. Hepatology,2019.[Epub ahead of print]
|
|
[21] WANG Q,SELMI C,ZHOU X,et al. Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis[J]. J Autoimmun,2013,41:140-145.
|
|
[22] ZHANG W,DE D,MOHAMMED KA,et al. New scoring classification for primary biliary cholangitis-autoimmune hepatitis overlap syndrome[J]. Hepatol Commun,2018,2(3):245-253.
|
|
[23] LINDOR KD,GERSHWIN ME,POUPON R,et al. Primary biliary cirrhosis[J]. Hepatology,2009,50(1):291-308.
|
|
[24] JOSHI S,CAUCH-DUDEK K,WANLESS IR,et al. Primary biliary cirrhosis with additional features of autoimmune hepatitis:Response to therapy with ursodeoxycholic acid[J]. Hepatology,2002,35(2):409-413.
|
|
[25] CHAZOUILLRES O,WENDUM D,SERFATY L,et al. Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome[J]. J Hepatol,2006,44(2):400-406.
|
|
[26] OZASLAN E,EFE C,HEURGU-BERLOT A,et al. Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis[J]. Clin Gastroenterol Hepatol,2014,12(5):863-869.
|
|
[27] NICOLL AJ,ROBERTS SK,LIM R,et al. Beneficial response to mycophenolate mofetil by patients with autoimmune hepatitis who have failed standard therapy,is predicted by older age and lower immunoglobulin G and INR levels[J]. Aliment Pharmacol Ther,2019,49(10):1314-1322.
|
|
[28] HANOUNEH M,RITCHIE MM,ASCHA M,et al. A review of the utility of tacrolimus in the management of adults with autoimmune hepatitis[J]. Scand J Gastroenterol,2019,54(1):76-80.
|
|
[29] BAVEN-PRONK AM,COENRAAD MJ,van BUUREN HR,et al. The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes[J]. Aliment Pharmacol Ther,2011,34(3):335-343.
|
|
[30] SHEN Y,FAN X,YANG X,et al. Letter:Tacrolimus may be hazardous in decompensated autoimmune liver disease with hyperbilirubinaemia[J]. Aliment Pharmacol Ther,2018,47(11):1566-1568.
|
|
[31] FAN X,ZHU Y,MEN R,et al. Efficacy and safety of immunosuppressive therapy for PBC-AIH overlap syndrome accompanied by decompensated cirrhosis:A real-world study[J].Can J Gastroenterol Hepatol,2018,2018:1965492.
|
|
[32] TRIVEDI PJ,HIRSCHFIELD GM. Review article:Overlap syndromes and autoimmune liver disease[J]. Aliment Pharmacol Ther,2012,36(6):517-533.
|
|
[33] CZAJA AJ,CARPENTER HA. Autoimmune hepatitis overlap syndromes and liver pathology[J]. Gastroenterol Clin North Am,2017,46(2):345-364.
|
|
[34] YANG F,WANG Q,WANG Z,et al. The natural history and prognosis of primary biliary cirrhosis with clinical features of autoimmune hepatitis[J]. Clin Rev Allergy Immunol,2016,50(1):114-123.
|
|
[35] MARTNEZ CASAS OY,DAZ RAMREZ GS,MARN ZULUAGA JI,et al. Autoimmune hepatitis-primary biliary cholangitis overlap syndrome. Long-term outcomes of a retrospective cohort in a university hospital[J]. Gastroenterol Hepatol,2018,41(9):544-552.
|
|
[36] CORPECHOT C,CARRAT F,POUPON R,et al. Primary biliary cirrhosis:Incidence and predictive factors of cirrhosis development in ursodiol-treated patients[J]. Gastroenterology,2002,122(3):652-658.
|
|
[37] HUET PM,VINCENT C,DESLAURIER J,et al. Portal hypertension and primary biliary cirrhosis:Effect of long-term ursodeoxycholic acid treatment[J]. Gastroenterology,2008,135(5):1552-1560.
|
|
[38] European Society of Gastrointestinal Endoscopy,European Association for the Study of the Liver,European Association for the Study of the Liver. Role of endoscopy in primary sclerosing cholangitis:European Society of Gastrointestinal Endoscopy(ESGE)and European Association for the Study of the Liver(EASL)clinical guideline[J]. J Hepatol,2017,66(6):1265-1281.
|
|
[39] GREGORIO GV,PORTMANN B,KARANI J,et al. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood:A 16-year prospective study[J]. Hepatology,2001,33(3):544-553.
|
|
[40] KERKAR N,CHAN A. Autoimmune hepatitis,sclerosing cholangitis,and autoimmune sclerosing cholangitis or overlap syndrome[J]. Clin Liver Dis,2018,22(4):689-702.
|
|
[41] ABDO AA,BAIN VG,KICHIAN K,et al. Evolution of autoimmune hepatitis to primary sclerosing cholangitis:A sequential syndrome[J]. Hepatology,2002,36(6):1393-1399.
|
|
[42] TRIVEDI PJ,CHAPMAN RW. PSC,AIH and overlap syndrome in inflammatory bowel disease[J]. Clin Res Hepatol Gastroenterol,2012,36(5):420-436.
|
|
[43] TRIVEDI PJ,HIRSCHFIELD GM. Review article:Overlap syndromes and autoimmune liver disease[J]. Aliment Pharmacol Ther,2012,36(6):517-533.
|
|
[44] KAYA M,ANGULO P,LINDOR KD. Overlap of autoimmune hepatitis and primary sclerosing cholangitis:An evaluation of a modified scoring system[J]. J Hepatol,2000,33(4):537-542.
|
|
[45] van BUUREN HR,van HOOGSTRATEN H,TERKIVATAN T,et al. High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis[J]. J Hepatol,2000,33(4):543-548.
|
|
[46] LINDOR KD,KOWDLEY KV,LUKETIC VA,et al. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis[J]. Hepatology,2009,50(3):808-814.
|
|
[47] FICKERT P,HIRSCHFIELD GM,DENK G,et al. nor Ursodeoxycholic acid improves cholestasis in primary sclerosing cholangitis[J]. J Hepatol,2017,67(3):549-558.
|
|
[48] CHAPMAN R,FEVERY J,KALLOO A,et al. Diagnosis and management of primary sclerosing cholangitis[J]. Hepatology,2010,51(2):660-678.
|
|
[49] LTH S,KANZLER S,FRENZEL C,et al. Characteristics and long-term prognosis of the autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome[J]. J Clin Gastroenterol,2009,43(1):75-80.
|
|
[50] FLOREANI A,RIZZOTTO ER,FERRARA F,et al. Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome[J]. Am J Gastroenterol,2005,100(7):1516-1522.
|
|
[51] OLSSON R,GLAUMANN H,ALMER S,et al. High prevalence of small duct primary sclerosing cholangitis among patients with overlapping autoimmune hepatitis and primary sclerosing cholangitis[J]. Eur J Intern Med,2009,20(2):190-196.
|
|
[52] Chinese Society of Hepatology,Chinese Medical Association;Chinese Society of Gastroenterology,Chinese Medical Association; Chinese Society of Infectious Diseases,Chinese Medical Association. Consensus on the diagnosis and management of autoimmune hepatitis(2015)[J]. J Clin Hepatol,2016,32(1):9-22.(in Chinese)中华医学会肝病学分会，中华医学会消化病学分会，中华医学会感染病学分会．自身免疫性肝炎诊断和治疗共识(2015)[J]．临床肝胆病杂志，2016,32(1):9-22.
|
|
[53] MANDOLESI D,LENZI M,D'ERRICO A,et al. Primary biliary cholangitis-primary sclerosing cholangitis in an evolving overlap syndrome:A case report[J]. Gastroenterol Hepatol,2017,40(10):669-671.
|
|
[54] SUNDARAM S,S K,MAZUMDAR S,et al. Overlap syndrome between primary biliary cholangitis and primary sclerosing cholangitis[J]. ACG Case Rep J,2018,5:e54.
|
|
[55] KINGHAM JG,ABBASI A. Co-existence of primary biliary cirrhosis and primary sclerosing cholangitis:A rare overlap syndrome put in perspective[J]. Eur J Gastroenterol Hepatol,2005,17(10):1077-1080.
|
|
[56] STIEHL A. Ursodeoxycholic acid therapy in treatment of primary sclerosing cholangitis[J]. Scand J Gastroenterol Suppl,1994,204:59-61.
|
|
[57] CHAYANUPATKUL M,FIEL MI,SCHIANO TD. The clinical characteristics,pre-and post-liver transplantation outcomes in patients having autoimmune overlap syndromes[J].Clin Transplant,2020:e13841.
|
DownLoad: